41 | Add to Reading ListSource URL: www.adityabirlanuvo.comLanguage: English - Date: 2010-11-29 05:02:31
|
|---|
42 | Add to Reading ListSource URL: www.adityabirlanuvo.netLanguage: English - Date: 2010-11-29 05:02:31
|
|---|
43 | Add to Reading ListSource URL: www.adityabirlanuvo.netLanguage: English - Date: 2014-07-04 08:41:18
|
|---|
44![Aditya Birla Nuvo Ltd. Transcript of FY14 earnings call held on 20th May[removed]Management Team:](https://www.pdfsearch.io/img/0135192c682cb7def35b9f8a87e47986.jpg "Aditya Birla Nuvo Ltd. Transcript of FY14 earnings call held on 20th May[removed]Management Team:") | Add to Reading ListSource URL: www.adityabirlanuvo.comLanguage: English - Date: 2014-05-30 01:57:04
|
|---|
45![Aditya Birla Nuvo Ltd. Transcript of FY14 earnings call held on 20th May[removed]Management Team:](https://www.pdfsearch.io/img/bcb9559cd5e02cc23c329024aa60aed2.jpg "Aditya Birla Nuvo Ltd. Transcript of FY14 earnings call held on 20th May[removed]Management Team:") | Add to Reading ListSource URL: www.adityabirlanuvo.netLanguage: English - Date: 2014-05-30 01:57:04
|
|---|
46 | Add to Reading ListSource URL: www.adityabirlanuvo.comLanguage: English - Date: 2012-12-06 04:47:40
|
|---|
47![NUVO RESEARCH ANNOUNCES DIRECTOR ELECTION RESULTS OF ITS ANNUAL GENERAL MEETING MISSISSAUGA, ON, June 11, [removed]Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of topical and im](https://www.pdfsearch.io/img/1a973e026e1184773f678d94d0e23df6.jpg "NUVO RESEARCH ANNOUNCES DIRECTOR ELECTION RESULTS OF ITS ANNUAL GENERAL MEETING MISSISSAUGA, ON, June 11, [removed]Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of topical and im") | Add to Reading ListSource URL: www.nuvoresearch.comLanguage: English - Date: 2014-06-11 15:14:48
|
|---|
48![NUVO RESEARCH® ANNOUNCES U.S. FDA APPROVAL OF THIRD-PARTY GENERIC OF PENNSAID® 1.5% MISSISSAUGA, Ontario, Canada - May 29, [removed]Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfol](https://www.pdfsearch.io/img/05573da8e0cea1a2448168bcf98589ab.jpg "NUVO RESEARCH® ANNOUNCES U.S. FDA APPROVAL OF THIRD-PARTY GENERIC OF PENNSAID® 1.5% MISSISSAUGA, Ontario, Canada - May 29, [removed]Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfol") | Add to Reading ListSource URL: www.nuvoresearch.comLanguage: English - Date: 2014-05-29 07:43:39
|
|---|
49![NUVO RESEARCH TO PRESENT AT BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE MISSISSAUGA, ON, June 17, [removed]Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of topical and immun](https://www.pdfsearch.io/img/455d8e706696b56cd8c661a557166c6a.jpg "NUVO RESEARCH TO PRESENT AT BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE MISSISSAUGA, ON, June 17, [removed]Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of topical and immun") | Add to Reading ListSource URL: www.nuvoresearch.comLanguage: English - Date: 2014-06-17 12:28:39
|
|---|
50 | Add to Reading ListSource URL: www.nuvoresearch.comLanguage: English - Date: 2014-06-18 11:24:16
|
|---|